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Abstract 
In this Conference Report, we present a summary of the key highlights and themes of 
the 13th World Congress of the International Association of Bioethics, which took 
place in Edinburgh, Scotland 14-17 June 2016 (IAB2016).  
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1. Introduction 
For the first time since 2000, the World Congress of the International Association of 
Bioethics (IAB) returned to the United Kingdom. This year, the Scots hosted the 
world’s largest gathering of bioethicists at the Edinburgh Congress, welcoming over 
700 delegates from 44 countries. In addition to the typical academic focus of such 
meetings, IAB2016 offered dedicated programmes on Arts+Ethics and for Early 
Career Researchers (ECRs). We members of the Liminal Spaces Project,2 hosted by 
Edinburgh Law School and funded by the Wellcome Trust, were present for the 
duration of the Congress. In this Conference Report, we offer an account of some of 
the key highlights and themes.  
2. Key Highlights and Themes 
2.1 Aesthetics 
Aesthetics is understood to influence how we make sense of and construct our worlds. 
Social scientists and humanities scholars examine the social dimensions of taste – 
whether in making sense of why we prefer a particular musical genre or in examining 
ideas of beauty – and the ways in which notions of what counts as “good” circulate 
within the domain of aesthetics. It is fitting, therefore, that aesthetics was a central 
theme at the Congress, both inside and outside of the Art+Ethics stream. In their 
keynote speeches, Paul Macneil (University of Sydney) discussed the centrality of the 
arts to understandings of bioethics, and Catherine Belling (Northwestern University) 
movingly described the impact of anaesthetic disruption on patients’ memories and 
personal narratives.  
A number of exhibitions and performances, organised by the Arts+Ethics Research 
Group, provided delegates with the opportunity to think about the centrality of form in 
medicine and meditate on non-verbal ways to represent health, ethics, pathology, and 
power. In Vishal Shah’s poignant sound sculpture, “Velum,” photographed skin was 
fed through a computer algorithm and visualised on screen, contorting with the music 
of an exuberantly played double bass. Irish artist Louise O’Boyle displayed materials 
in scientific vessels, raising questions about ownership of human body parts. Bela 
Fishbyn’s photograph, “Tatar Couple,” captured health, ethics, and care in a simple, 
gripping image of an elderly couple being still with each other in their home. These 
and the eleven other still pieces moved the everyday into ethics and ethics into the 
everyday, challenging our common understandings of care, ownership, biology, and 
data.  
The centrality of aesthetics to ethical considerations also featured in many of the 
panel and symposia discussions. Speakers brought to the fore how regulatory 
commitments are mediated by the approach we take to understanding the human self 
and illness. The questions “What is human?” and “What is normal?” circulated 
through panels on topics as diverse as enhancement, relational ethics, and 
vulnerability. A Nuffield Council on Bioethics symposium, “Ethics and Regulation of 
                                                 
2 Liminal Spaces Project, available at http://www.liminalspaces.ed.ac.uk/ (accessed 10 Aug 16). 
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Global Beauty Practices and Procedures,” generated lively conversation on the need 
to govern globalised cosmetic interventions. In a parallel session on “Vulnerability, 
Treatment and Relationships,” Karin Jongsma (UMC Gottingen) analysed patient 
groups, demonstrating profound differences between how the needs of individuals are 
represented depending on whether a group is constituted of, or for, people with a 
disease such as autism. Examining breast screening programs, Harold Schmidt 
(University of Pennsylvania) showed the diversity of images and approaches used to 
persuade women to undergo testing. His analysis revealed how the number of “life-
saving” procedures is often measured through interventions, rather than actual 
detection and treatment of breast cancer. Finally, in a panel on Science and 
Technology Studies (STS) and bioethics, organised by Catherine Heeney (University 
of Edinburgh), speakers reflected on how facts and values become entwined, and 
particuarly how representations of biology dovetail with normative commitments in 
science and medicine. 
2.2 Early Career Researchers 
In recognition of the importance of supporting ECRs, IAB2016 offered a dedicated 
series of events tailored towards more junior delegates. The ECR thread included a 
session where three keynote speakers (Alastair Campbell, Sarah Chan, and Anant 
Bhan) each offered distinctive reflections on careers in bioethics. Campbell laid out 
the changing landscape of bioethics, which he has observed throughout his career. 
Bhan considered the various ways in which we can contribute to bioethics and related 
fields through advocacy, as well by traditional academic means. Chan comforted 
those of us who might suffer from existential angst about self-identifying as 
“bioethicists,” encouraging us to think beyond pre-existing approaches and to be more 
critical of received narratives of science and medicine.  
In addition to the keynote, three ECR Master Classes were held on (i) oral 
presentations, (ii) publications, and (iii) funding, policy, and career advancement. 
Each of these sessions featured experienced senior scholars recognised for their 
communication skills and achievements. In the master class on oral presentations, 
delegates were treated to presentions from Florencia Luna (FLACSO, Argentina) 
Muireann Quigley (Newcastle University), Inez de Beaufort (Erasmus Medical Centre 
for Rotterdam), and Julien Savulescu (Uehiro Centre for Practical Ethics, Oxford).  
In the session on publications, Heather Widdows (University of Birmingham) 
discussed the importance of publication planning for one’s academic career, including 
what and when (and when not) to publish and for what reasons. In addition to 
stressing that not all publications are equal – and, therefore, encouraging ECRs to put 
the most energy into research-focused publications that advance their field – 
Widdows’ advised ECRs ultimately to “just do it”: to plan, prioritise, and produce 
publications throughout their careers. Dominic Wilkinson (Uehiro Centre for Practical 
Ethics, University of Oxford and editor of the Journal of Medical Ethics) described 
how editors make decisions about papers to send for review, how they select 
reviewers, and how they make decisions on which papers to accept. Wilkinson noted 
that there are three crucial stages for every author to consider: (i) getting the paper 
past the editor’s initial triaging process for deciding whether it is interesting, novel, 
and of relevance to the field; (ii) getting it through the peer review process; and (iii) 
getting it to acceptance and publication. Many ECRs in the audience appreciated 
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Wilkinson’s inside knowledge of the editorial process and his frank discussion of the 
“tricks of the trade.” Finally, Graeme Laurie (University of Edinburgh) presented on 
monographs, drawing on his experiences as joint editor of Cambridge University 
Press’s Bioethics and Law series. Laurie advised ECRs on what a commissioning 
editor looks for – e.g. whether there is a market for the book proposal, especially in 
America – what raises red flags, and how to pitch successfully to an editor. He 
encouraged ECRs to think about the originality, significance, and rigour of their work. 
He also offered tips on improving a book proposal, as well as potential publishing 
strategies for ECRs, and thoughts on the challenges of publishing multi- versus inter-
disciplinary pieces. All three presenters emphasised the crucial need for the ECR to 
find their “research voice” and produce research-focused, high quality publications. 
Panel members for the Funding, Policy and Careers Master Class were Hugh Whittall 
(Nuffield Council on Bioethics), Ilina Singh (Oxford Centre for Neuroethics), Dan 
O’Connor (Wellcome Trust), and Nils Hoppe (CELLS, University of Hannover). 
Whittall offered insights into working on policy issues, suggesting that, in order to 
effectively influence policy, it is crucial to identify key issues in a timely manner and 
understand when action can be taken. Singh encouraged us to present and advocate 
for our research as often as possible, and to appreciate that “impact” can often take 
time and occur further downstream from the research itself. She also highlighted the 
use of social media as a powerful tool for the dissemination of work. O’Connor 
offered entertaining and valuable instruction from a funder’s perspective. He 
suggested that career narratives should be structured around creating a brand, value, 
and story, and that attractive funding applications always communicate how the 
funders’ agenda is advanced through the applicants work, and repeatedly refer back to 
this point. Finally, Hoppe encouraged us to snap up opportunities to present our work, 
to network, to contribute to our communities, to collaborate beyond our own 
disciplines, and to take risks.  
2.3 HeLa 
The internationally acclaimed and award-winning theatre production of HeLa was 
much anticipated after an intense opening day of plenary and parallel sessions. Adura 
Onashile’s electric performance told the story of the life and death of Henrietta Lacks 
and the HeLa cell line, which originated from a cancerous tumour biopsy taken from 
Lacks shortly before her untimely death in 1951, and which was used without her 
consent. Based on Rebecca Skloot’s praised book, The Immortal Life of Henrietta 
Lacks,3 Onashile brought Lacks to life, as well as sensitively portraying her family 
and the part they played in seeking recognition for their mother’s significant but 
unknowing contribution to science. As Onashile marked up the names of the men who 
had been recognised for their work on the HeLa cell line, and the scientific advances 
that had resulted, this served to starkly illustrate the absence of the woman who had 
made this work possible. Changing pace with ease, she captured Lacks’ energy in life, 
as well as her deep love for the young family that she left behind. The audience were 
brought to their feet by the emotional breadth of Onashile’s performance. 
                                                 
3 Rebecca Skloot, The Immortal Life of Henrietta Lacks (New York: Crown, 2010). 
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In the question-and-answer session that followed the performance, IAB delegates 
sought to understand what had motivated Onashile to tackle Skloot’s text. Her answer 
was simple: “anger,” coupled with a desire to promote the contribution that Lacks had 
made, in accordance with her family’s wishes. In this vein, delegates probed the 
extent to which the Lacks family had consented to the performance. Onashile 
confirmed that she had contacted the family to seek and obtain their agreement. 
Delegates who teach the book to students highlighted the ongoing relevance of 
interwoven strands contained within the HeLa story – of poverty, racism, and injustice 
– in the context of the use of human tissue without consent for scientific endeavour 
and ultimately financial profit. 
2.4 Public Interest, Public Engagement, and Public Good  
At the heart of the HeLa production was a consideration central to the public interest 
strand of IAB2016 – the interplay between autonomy and the rights of the individual, 
on one hand, and the wider public interest(s) or public benefit(s) on the other. There 
was a clear appetite amongst those presenting and attending IAB2016 to scrutinise 
how public interests are understood, articulated, framed, and implemented in a range 
of contexts. Three cross-cutting themes emerged at the Congress from this multi-
disciplinary examination of the public interest: 1) the framing of the approach to the 
public interest; 2) public engagement and the role of empirical research in better 
understanding public interest; and 3) the operationalisation of the public interest. 
Speakers at the Wellcome Trust-sponsored Liminal Spaces Project symposium, 
“What Does It Mean to Regulate in the Public Interest?”, described challenges in the 
definition, scope, and implementation of the public interest in a rich, cross-
disciplinary consideration that drew on philosophy, law, and the humanities. Leslie 
Stevens (University of Edinburgh) set the scene, proposing the adoption of a public 
interest mandate in order to refocus attention onto the public nature of administrative 
data, and to inform how public authorities value, and act upon, the data they hold. In 
doing so, she clearly drew out how the public interest could be used to address the 
barriers to data sharing identified in her work. David Townend (Maastricht 
University) focussed on the relationship between personal responsibility and the 
public interest, examining the extent to which the primacy given to autonomy places 
the notion of the public interest at odds with expectations of privacy. Alongside this, 
Alena Buyx (University of Kiel) considered the concept of solidarity in examining 
what it means to regulate in the public interest, highlighting the extent to which these 
concepts do and do not overlap, and thus whether and how the interests and rights of 
individuals can be compatible with notions of public interest. Annette Rid (King’s 
College London) also sought to reframe the debate around health research regulation, 
drawing on a proportionate governance model to argue that protecting the interests of 
research participants is an essential part of regulating health research in the public 
interest. Finally, Mark Taylor (University of Sheffield) unpacked the concept of the 
public interest in the context of the use of patient confidential data for public policy 
objectives. In doing so, he emphasised that the public interest is not something to be 
balanced against privacy; instead, each can place limits upon the other because each 
should be accounted for in a conception of the other. Taylor’s touchstone here was a 
recognition of the need for legitimacy: what can publics reasonably expect will 
happen with their data and which is in the public interest? 
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Public engagement was a thread that ran through these discussions of public interest. 
In the “Health Research Consortia” parallel session, Sarah Cunningham-Burley 
(University of Edinburgh) considered public good arguments in the context of the use 
of linked data for research purposes. She drew on evidence from a range of public 
engagement activities to identify the multiple meanings of public good and 
researching in the public interest, and how these might be deployed in future 
governance structures. In particular, she highlighted how public benefit can be 
perceived and conceptualised in different ways – both by researchers and by publics – 
and cautioned against top-down approaches that might limit debate. At the Farr 
Institute-sponsored symposium, “Governance Interoperability in Health Research 
Regulation,” speakers built on this empirical theme, further examining the patient 
experience and the interface between patients and practitioners. Nathan Lea 
(University College London) focussed on the expectations formed by patients and 
practitioners as information is shared and reused beyond the therapeutic context. 
Adrian Thorogood (McGill University) presented the work of the Global Alliance for 
Genomics and Health in promoting effective and responsible sharing of genomic and 
health-related data. Leslie Stevens (University of Edinburgh) presented on the 
persistent cultural, sectoral, and technical barriers to sharing data across sectors in the 
UK. Finally, Don Willison (University of Toronto) presented data on patients’ 
perspectives on appropriate flows of information. 
In the final keynote address of the Congress, Baroness Onora O’Neill (University of 
Cambridge) addressed the topic of “Public Goods and Private Data.” True to form, 
O’Neill offered a biting critique of the terms of the forthcoming European General 
Data Protection Regulation, arguing that its focus on content – the illusive construct 
of “personal data” – rather than on acts or behaviours that impact on citizens’ privacy 
– is a failure of law both to capture and regulate what is important about privacy and 
also to deliver effective and responsible data sharing in the name of the public good. 
2.5 Justice and Global Bioethics 
There was a time in bioethics when the concept of justice was often confined to 
questions associated with resource allocation. Typically this was framed as the right 
to health (care), resource allocation, or priority setting in health care on the one hand, 
and on the other hand, considerations of fairness in the selection of research 
participants, standard of care during trials, and post-trial access to new drugs and 
therapy. While broader considerations informed and structured each of these debates, 
IAB2016 was a testimony to how bioethics, both local and global, is increasingly 
attuned to deeper and richer considerations of justice, including relational and 
structural aspects, and concerns beyond states and borders. 
The two FAB4-IAB crossover keynote addresses by Lisa Eckenwiler (George Mason 
University) and Florencia Luna (FLACSO, Buenos Aires) established the significance 
of this topic. Eckenwiler illustrated the importance of place in considerations of 
justice in public health, describing it as a crucial aspect of the social determinants of 
health. She called for a bio-centred egalitarianism that would recognise the 
importance of ethical-placemaking for humans and their environment. With further 
                                                 
4 Feminist Approaches to Bioethics, available at http://fabnet.org/ (accessed 10 Aug 16). 
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attention to structural justice, Luna brought a gender lens to Zika as a public health 
and humanitarian crisis. Showing how women are disproportionately and unjustly 
affected both by the consequences of the disease and the policies surrounding it, Luna 
called for public health to be a voice of social conscience, setting the framework for 
empowerment. 
Thus, both the global nature of bioethics and its close links to considerations of 
justice, understood broadly, were set out early in the Congress. This theme was then 
developed in further keynote addresses. Gillian Brock (University of Auckland) 
shared her expertise on the global medical brain drain, evaluating the practical steps 
low-income countries could take to retain medical skills within their borders, and so 
establishing a platform for discussing rights and obligations from the perspective of 
countries that otherwise tend to be on the receiving end of global justice perspectives. 
Echoing the need to incorporate the voice(s) of the Global South, Ashok Acharya 
(University of Delhi) problematised some of the assumptions often underlying the 
Global North-Global South divide. Finally, sociologist Alondra Nelson’s (Columbia 
University) presentation on her qualitative research of genetic ancestry in the USA 
revealed how genomic testing intersects with personal histories and legal claims in 
novel ways. Her African-American interlocutors engage with ancestry testing to both 
produce knowledge about themselves and to sue persons that engaged in the 
transatlantic slave trade. The legitimacy of ancestry genetics, therefore, appears to be 
established more by courts than by genetic experts. 
Several of the parallel sessions also highlighted the various tensions in global justice 
and global bioethics. For example, in an inspiring session exploring these tensions, 
“Problematizing Assumptions Underlying the ‘Global South-Global North’ 
Geographical Imaginary,” several scholars illustrated the problems associated with 
seeming neutral terms such as “collaboration” or “capacity-building,” using English 
as the default language in policy documents (rendering terms and concepts resistant to 
adequate translation on the ground), and the need for equalising partnerships. Finally, 
just prior to a handover session to the next IAB organisers (IAB2018 in New Delhi, 
India) – which is aptly titled, “Health for All in an Unequal World” – IAB President 
Angela Ballantyne (University of Otago) once again highlighted considerations of 
justice in global health when presenting on the ethical and fairness aspects of 
surrogacy in India. 
2.6 New Reproductive Frontiers 
Throughout IAB2016, the variety of bioethical issues associated with advances in 
technological, ethical, and philosophical approaches to reproduction resonated 
strongly. There were several sessions on mitochondrial donation (MD), artificial 
gametes, ectogenesis, abortion rights and ethics, conscientious objection, and cross-
border commercial surrogacy. The presentations and discussions on reproductive 
technologies provided original and thought-provoking analysis. 
In the symposium on “Ethical Questions in Mitochondrial Donation”, Reuven Brandt 
and  Stephen Wilkinson (both of Lancaster University), Ainsley Newson (University 
of Sydney), and Colin Gavaghan (University of Otago) explored the ethical and 
philosophical questions raised by this new technology, namely: personal identity and 
the right to know; the appropriate role of public consultation; the nature of the 
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relationship between donors and resulting children; and the extent of the normative 
weight that we should apply to “parental preferences” in this context. Their 
presentations highlighted that while mitochondrial donation may be beneficial, the 
debates resulting from regulation of this technology in the UK leave much to be 
desired. The later symposium on “UK Mitochondrial Research and Legislation: 
Cutting Edge or Out on a Limb?” continued in this vein, providing stimulating 
analysis of the challenges and opportunities in the regulations, and salient questions 
about the UK’s legislative motive for this. In a series of complementary talks, Erica 
Haimes and Ken Taylor (both of Newcastle University) criticised the current UK 
debates for their lack of nuance and questioned the depth and rigor of prior debates. 
Meanwhile, Cathy Herbrand (DeMontfort University) discussed the practical 
limitations of this regulatory attempt to “eradicate” mitochondrial disease. IIke 
Turkmendag (Sheffield University) highlighted the implicit significance of donated 
genetic material in these debates and provided a persuasive case for a different 
legislative conception of access to mitochondrial donors’ identifiable information. 
Finally, Annelien Bredenoord (UMC Utrecht) described the importance of context in 
“copying-and-pasting” the UK’s legislative answer to the US. Both symposia 
explored this topical area in an innovative manner, providing new challenges to a 
debate that has seemingly been put to rest by many, and adding much needed analysis 
to the quiet that has ensued since the UK’s regulations came into force. 
Parallels may be drawn with the symposium on “The Ethics of Human ‘Artificial 
Gametes,’” which persuasively tackled a controversial area from varied angles, tying 
together new social considerations, such as reproduction for new forms of family, 
with the old, including genetic parenthood. John Appleby (King’s College London) 
recommended that enrolment in clinical trials should be mandatory for the first 
parents of artificial gametes in order to benefit the ethical interests of parents, 
children, families, clinicians, researchers, and also society. Daniela Cutas (King’s 
College London) reviewed the ethics of “solo” human reproduction, claiming that 
there are convincing arguments for pursuing research that enables solo reproduction. 
César Palacios-González (Umeå University) argued that in-vitro gametogenesis 
undermines the arguments against same-sex marriage advanced by the “new natural 
lawyers.” Finally, Heidi Mertes (Ghent University) considered the ethical issues of 
deriving gametes from embryos created through fertilisation, arguing that a good 
reason for pursuing this research is that it might enable mutual genetic parenthood for 
same-sex couples. 
3. Conclusion 
The overarching question for the IAB2016 World Congress was: “What is the 
contribution of bioethics?” The Congress’s focus on individuals, public interests, and 
public goods delivered a programme comprising over 70 parallel sessions, with 
almost 250 speakers addressing this crucial question in myriad forms. The enduring 
legacy of IAB2016 must be that this inquiry remains at the forefront of all 
contributions of colleagues who work in the field of bioethics. We wish the organisers 
of IAB2018 every success in the task of carrying forward this responsibility. 
